Participants 52 72 3
uremic pericarditis.
Participants 207 388 9
24 patients with endstage chronic renal failure and pericarditis randomly received indomethacin, 25 mg four times daily, (11 patients) or a placebo (13 patients) for a 3-week period
Participants 390 481 3
All patients received peritoneal or hemodialysis treatment concurrently with the study drug
